Journal of Clinical Virology
Volume 46 , Pages S54-S57 , December 2009

Findings and conclusions from CMV hyperimmune globulin treatment trials

  • Stuart P. Adler

      Affiliations

    • Department of Pediatrics, Virginia Commonwealth University, Medical College of Virginia Campus, Box 163, Richmond, VA 23298, United States
    • Corresponding Author InformationCorresponding author.
    • ,
  • Giovanni Nigro

      Affiliations

    • Department of Pediatrics, University of L’Aquila, L’Aquila, Italy

Received 31 March 2009 ,Revised 25 August 2009 ,Accepted 29 August 2009.

References 

  1. Stratton KR, Durch JS, Lawerence RS. Vaccines for the 21st century: a tool for decision making. Washington, DC: National Academy Press; 2000;
  2. Cui X, Meza MP, Adler SP, McVoy MA. Human immune sera contain high titers of antibodies that block cytomegalovirus entry into epithelial cells but are induced at low titers by CMV vaccines. Vaccine. 2008;26:5760–5766
  3. Clark AL, Gall SA. Clinical uses of intravenous immunoglobulin in pregnancy. Am J Obstet Gynecol. 1997;176:241–253
  4. Ballow M. Intravenous immunoglobulins: clinical experience and viral safety. J Am Pharm Assoc. 2002;42:449–458
  5. Ballow M. Safety of IGIV therapy and infusion-related adverse events. Immunol Res. 2007;38:122–132
  6. Schleiss MR. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model. J Clin Virol. 2008;41:224–230
  7. Bia FJ, Griffith BP, Tarsio M, Hsiung GD. Vaccination for the prevention of maternal and fetal infection with guinea pig cytomegalovirus. J Infect Dis. 1980;142:732–738
  8. Chatterjee A, Harrison CJ, Britt WJ, Bewtra C. Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs. J Infect Dis. 2001;183:1547–1553
  9. Bratcher DF, Bourne N, Bravo FJ, Schleiss MR, Slaoui M, Myers MG, et al. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs. J Infect Dis. 1995;172:944–950
  10. Gabrielli L, Bonasoni P, Lazzarotto T, Lega S, Santini D, Foschini MP, et al. Histological findings in fetuses congenitally infected by cytomegalovirus. J Clin Virology; in press.
  11. Cekinović D, Golemac M, Pugel EP, Tomac J, Cicin-Sain L, Slavuljica I, et al. Passive immunization reduces murine cytomegalovirus-induced brain pathology in newborn mice. J Virol. 2008;82:12172–12180
  12. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992;326:663–667
  13. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–276
  14. Bodeus M, Hubinont C, Goubau P. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet Gynecol. 1999;93:658–660
  15. Enders G, Bader U, Lindemann L, Schalasta G, Daiminger A. Diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn. 2001;21:362–377
  16. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005;353:1350–1362
  17. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol. 2006;35:216–220
  18. Ross SA, Fowler KB, Ashrith G, Stagno S, Britt WJ, Pass RF, et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr. 2006;148:332–336
  19. Doyle M, Atkins JT, Rivera-Matos IR. Congenital cytomegalovirus infection in infants infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1996;15:1102–1106
  20. Chandwani S, Kaul A, Bebenroth D, Kim M, John DD, Fidelia A, et al. Cytomegalovirus infection in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J. 1996;15:310–314
  21. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 2001;344:1366–1371
  22. Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B, et al. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics. 2006;117:e76–83
  23. Stagno S, Britt W. Cytomegalovirus infections. Infectious diseases of the fetus and new born infant. 6th edition. Remington and Klein; 2006;p.739–781
  24. Naeye RL. Cytomegalic inclusion disease. The fetal disorder. Am J Clin Pathol. 1967;47:738–744
  25. La Torre R, Nigro G, Best AM, Adler SP. Placental enlargement is predictive of a primary maternal cytomegalovirus infection and fetal disease. Clin Infect Dis. 2006;43:994–1000
  26. Fowler KB, Stagno S, Pass RF. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA. 2003;289:1008–1011
  27. Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG. Prevention of transfusion acquired cytomegalovirus infection in newborn infants. J Pediatr. 1981;98:281–287
  28. Adler SP, Chandrika T, Lawrence L, Baggett J. Cytomegalovirus infections in neonates acquired by blood transfusions. Pediatr Infect Dis J. 1983;2:114–118
  29. Adler SP, Baggett J, Wilson M, Lawrence L, McVoy M. Molecular epidemiology of cytomegalovirus transmission in a nursery: lack of evidence for nosocomial transmission. J Pediatr. 1986;108:117–123
  30. Snydman DR, Werner BG, Meissner HC, et al. Use of cytomegalovirus immunoglobulin in multiple transfused premature neonates. Pediatr Infect Dis J. 1995;14:34–40
  31. Sissons JG, Carmichael AJ, McKinney N, Sinclair JH, Wills MR. Human cytomegalovirus and immunopathology. Springer Semin Immunopathol. 2002;24:169–185
  32. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun. 2001;16:175–186
  33. Nigro G, La Torre R, Pentimalli H, Taverna P, Lituania M, Martinez de Tejada B, et al. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn. 2008;28:512–517
  34. Sato A, Hirano H, Miura H, Hosoya N, Ogawa M, Tanaka T. Intrauterine therapy with cytomegalovirus hyperimmunoglobulin for a fetus congenitally infected with cytomegalovirus. J Obstet Gynaecol Res. 2007;33:718–721
  35. Moise KJ, Wolfe H. Treatment of second trimester fetal cytomegalovirus infection with maternal hyperimmune globulin. Prenat Diagn. 2008;28:264–265
  36. Moxley K, Knudtson EJ. Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol. 2008;111:524–526
  37. Duff P. A thoughtful algorithm for the accurate diagnosis of primary CMV infection in pregnancy. Am J Obstet Gynecol. 2007;196:196–197

PII: S1386-6532(09)00414-4

doi: 10.1016/j.jcv.2009.08.017

Journal of Clinical Virology
Volume 46 , Pages S54-S57 , December 2009

Article Tools